Trial Profile
Phase I study of single dose INCB 40093 in healthy volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 13 Mar 2014
Price :
$35
*
At a glance
- Drugs Dezapelisib (Primary)
- Indications Hodgkin's disease; Non-Hodgkin's lymphoma
- Focus Adverse reactions
- 13 Mar 2014 New trial record